Tumoral levels of phosphorylated STAT6 (p-STAT6) have been frequently detected in the colon of patients with clinically detectable IBD, and tumoral p-STAT6 positively correlates with the clinical stage and poor prognosis of human CRC [44]. Here, STAT6 is linked to colorectal carcinoma.